Months after Imfinzi combo flops, AstraZeneca wins NICE endorsement as lung cancer monotherapy

Months after Imfinzi combo flops, AstraZeneca wins NICE endorsement as lung cancer monotherapy - Endpoints News

- March 30, 2019

Months after Imfinzi combo flops, AstraZeneca wins NICE endorsement as lung cancer monotherapy Endpoints News

AstraZeneca's big bet on a combination of its checkpoint inhibitor Imfinzi and in-house CTLA-4 drug has proved exceedingly costly, but the British drugmaker ...

Search This Blog

Lung Cancer

Months after Imfinzi combo flops, AstraZeneca wins NICE endorsement as lung cancer monotherapy - Endpoints News

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago